MicroPort® Signs Strategic Partnership Agreement with China Medical Instrument

Shanghai, China – Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") recently signed a strategic partnership agreement with China Medical Instrument (Group) Co., Ltd. ("China Medical Instrument").
China Medical Instrument is a subsidiary of the largest healthcare company in China - China National Pharmaceutical Group Corporation ("SINOPHARM"), covering various business segments including sales, logistics, group purchasing, government centralizing procurement, and international trade. It is a strong player in distributing, retailing, developing and manufacturing medical devices.
MicroPort® Chief Marketing Officer Bo Peng said, "This partnership brings together two industry leaders. It is expected that this partnership will allow MicroPort® to leverage SINOPHARM's broad distribution channels and policy advantages and lay a good foundation for further cooperation. By sharing resources and leveraging complementary advantages in logistics and service, we hope to jointly promote the development of medical devices."